264 related articles for article (PubMed ID: 15528376)
1. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice.
Grainger DJ; Reckless J; McKilligin E
J Immunol; 2004 Nov; 173(10):6366-75. PubMed ID: 15528376
[TBL] [Abstract][Full Text] [Related]
2. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
Van Eck M; Van Dijk KW; Herijgers N; Hofker MH; Groot PH; Van Berkel TJ
Atherosclerosis; 2001 Jan; 154(1):103-12. PubMed ID: 11137088
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E induces antiinflammatory phenotype in macrophages.
Baitsch D; Bock HH; Engel T; Telgmann R; Müller-Tidow C; Varga G; Bot M; Herz J; Robenek H; von Eckardstein A; Nofer JR
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1160-8. PubMed ID: 21350196
[TBL] [Abstract][Full Text] [Related]
4. Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo.
Zanotti I; Pedrelli M; Potì F; Stomeo G; Gomaraschi M; Calabresi L; Bernini F
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):74-80. PubMed ID: 20966401
[TBL] [Abstract][Full Text] [Related]
5. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
Merched AJ; Chan L
Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
Falasca L; Iadevaia V; Ciccosanti F; Melino G; Serafino A; Piacentini M
J Immunol; 2005 Jun; 174(11):7330-40. PubMed ID: 15905580
[TBL] [Abstract][Full Text] [Related]
7. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
Yu KC; Jiang Y; Chen W; Cooper AD
J Lipid Res; 2000 Nov; 41(11):1715-27. PubMed ID: 11060341
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.
Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S
Circulation; 2011 Jul; 124(4):454-64. PubMed ID: 21730304
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
[TBL] [Abstract][Full Text] [Related]
10. Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.
Goldklang M; Golovatch P; Zelonina T; Trischler J; Rabinowitz D; Lemaître V; D'Armiento J
Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1200-8. PubMed ID: 22447954
[TBL] [Abstract][Full Text] [Related]
11. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.
Yancey PG; Blakemore J; Ding L; Fan D; Overton CD; Zhang Y; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):787-95. PubMed ID: 20150557
[TBL] [Abstract][Full Text] [Related]
12. Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke.
Han SG; Howatt DA; Daugherty A; Gairola CG
Toxicology; 2012 Sep; 299(2-3):133-8. PubMed ID: 22659316
[TBL] [Abstract][Full Text] [Related]
13. Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities.
Ito K; Nakashima H; Watanabe M; Ishimura A; Miyahara Y; Abe Y; Yasuno T; Ifuku M; Sasatomi Y; Saito T
Nephrol Dial Transplant; 2012 Oct; 27(10):3899-907. PubMed ID: 22863838
[TBL] [Abstract][Full Text] [Related]
14. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.
Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S
Circulation; 2005 May; 111(18):2373-81. PubMed ID: 15851589
[TBL] [Abstract][Full Text] [Related]
15. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
17. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.
Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S
Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.
Li K; Ching D; Luk FS; Raffai RL
Circ Res; 2015 Jun; 117(1):e1-e11. PubMed ID: 25904598
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
[TBL] [Abstract][Full Text] [Related]
20. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]